Of note, two days prior to admission, the pt had a CT scan of her torso that revealed progression of her disease throughout, including interval progression in abnormal pulmonary densities involving all lobes.
She was admitted to the [**Hospital Unit Name 153**] for further management.
Past Medical History: - Tuberculosis treated in [**2145**] with normal chest x-ray at [**Hospital1 2025**] in [**2162**].
- normal colonoscopy 2/[**2178**].
NEURO: Alert & appropriate   Pertinent Results: [**2181-12-2**] 01:08AM   WBC-10.0 RBC-4.28 HGB-14.7 HCT-43.9 MCV-103* MCH-34.3* MCHC-33.4 RDW-20.9* [**2181-12-2**] 01:08AM   NEUTS-89.7* LYMPHS-6.4* MONOS-3.6 EOS-0.2 BASOS-0 [**2181-12-2**] 01:08AM   PLT COUNT-194 [**2181-12-2**] 01:08AM   PT-16.7* PTT-33.3 INR(PT)-1.5* [**2181-12-2**] 01:08AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG [**2181-12-2**] 01:04AM   LACTATE-2.5* [**2181-12-2**] 01:08AM   GLUCOSE-193* UREA N-12 CREAT-0.6 SODIUM-135 POTASSIUM-4.2 CHLORIDE-101 TOTAL CO2-25 ANION GAP-13 [**2181-12-2**] 01:08AM   proBNP-338* [**2181-12-2**] 01:08AM   CALCIUM-8.1* PHOSPHATE-3.3 MAGNESIUM-1.8 [**2181-12-12**] 12:00AM BLOOD WBC-7.0# RBC-3.67* Hgb-12.5 Hct-38.8 MCV-106* MCH-34.1* MCHC-32.2 RDW-20.1* Plt Ct-147* [**2181-12-2**] 01:08AM BLOOD Neuts-89.7* Lymphs-6.4* Monos-3.6 Eos-0.2 Baso-0 [**2181-12-12**] 12:00AM BLOOD PT-14.9* PTT-23.9 INR(PT)-1.3* [**2181-12-12**] 12:00AM BLOOD Plt Ct-147* [**2181-12-3**] 11:31AM BLOOD Glucose-119* UreaN-14 Creat-0.5 Na-131* K-4.5 Cl-97 HCO3-29 AnGap-10 [**2181-12-12**] 03:21PM ASCITES WBC-11* RBC-[**Numeric Identifier 17260**]* Polys-15* Lymphs-46* Monos-0 Macroph-37* Other-2* [**2181-12-12**] 03:21PM ASCITES TotPro-2.6 Glucose-102 LD(LDH)-274 Albumin-1.4 .
Reports: CHEST (PORTABLE AP)  [**2181-12-1**] 11:49 PM SINGLE AP UPRIGHT BEDSIDE CHEST RADIOGRAPH: As seen on CT of the chest from one day prior, there are multiple large loculated pleural effusions, which appear roughly stable compared to one day prior.
There are bibasilar fluffy opacities, right greater than left, consistent with pneumonia as seen on CT from one day prior.
Bibasilar opacities, consistent with pneumonia as seen on CT from one day prior.
Compared to the prior tracing of [**2181-11-22**] atrial ectopy is no longer precorded.
TTE [**2181-12-1**] Left ventricular wall thickness, cavity size, and systolic function are normal (LVEF>55%).
Compared with the prior study (images reviewed) of [**2181-11-16**], the findings are similar (heart rate is slower).
female with metastatic adenocarcinoma of unknown primary first diagnosed in [**2181-5-10**] from percardiocentesis fluid cytology, recent cycle of capcitabine/irinotecan, history of PE/DVT s/P IVC filter and enoxparin therapy, and SVT secondary to malignancy, who was admitted from the ED to ICU for recurrent respiratory distress and tachycardia.
Despite diuretic therapy, antibiotic therapy, nebulizer treatments, heart rate control, and corticosteroid therapy, she did not improve substantially.
Given this, along with progression of disease on CT imaging in spite of receiving chemotherapy, it was eventually determined by primary oncology team and patient's family to pursue comfort measures only.
Secondary to malignancy, was on diltiazem for heart rate control to help with dyspnea.
Fluid bloody, fluid not indicative of SBP.
CMO  Medications on Admission: Calcium Carbonate 500 mg qid Cholecalciferol (Vitamin D3) 800 unit daily Fentanyl 25 mcg/hr Patch 72 hr Lidocaine patch Capecitabine 1500 mg [**Hospital1 **] Loperamide 2 mg qid prn Docusate Sodium 100 mg [**Hospital1 **] Senna 8.6 mg Tablet [**Hospital1 **] Megestrol 400 mg daily Hexavitamin daily Enoxaparin 60 mg/0.6 mL syringe [**Hospital1 **] Levalbuterol HCl nebs prn Ipratropium Bromide nebs Diltiazem HCl 120 mg daily   Discharge Medications: 1.
Artificial Saliva 0.15-0.15 % Solution Sig: 1-3 MLs Mucous membrane QID (4 times a day) as needed.
